WWOX
WWOX (WW domain containing oxidoreductase, also known as FOR, WOX1 and SDR41C1) is a putative oxidoreductase of the short-chain dehydrogenase/reductase family. It acts as a tumour suppressor and has roles in apoptosis and bone development. Browse Assay Genie's current range of WWOX research reagents below, or read on for the biology behind the target.
WWOX is a putative oxidoreductase that functions as a tumour suppressor and contributes to apoptosis. It is required for normal bone development and may act synergistically with p53/TP53 to control cell death induced by genotoxic stress. The protein also takes part in TGFB1 signalling and TGFB1-mediated cell death, and may contribute to cell death mediated by tumour necrosis factor (TNF). In addition, WWOX inhibits Wnt signalling, probably by sequestering DVL2 in the cytoplasm.
The WWOX protein belongs to the short-chain dehydrogenase/reductase (SDR) superfamily, and the enzyme is assigned EC 1.1.1.-. UniProt records its localisation in the cytoplasm, nucleus, mitochondrion, Golgi apparatus and lysosome. Alternative splicing of the WWOX gene results in multiple transcript variants. The mouse ortholog is Wwox, and disruption of a similar gene in mouse results in impaired steroidogenesis, which suggests an additional metabolic function for the protein.
The WWOX gene spans the FRA16D common chromosomal fragile site and appears to function as a tumour suppressor gene. Expression of the encoded protein can induce apoptosis, while defects in the gene are associated with multiple types of cancer. Disruption of WWOX is also associated with autosomal recessive spinocerebellar ataxia 12. The protein is also referred to as FOR, WOX1 and SDR41C1.
WWOX is a tumour suppressor, and defects in the gene are associated with multiple types of cancer.
The protein induces apoptosis and may work with p53 and TNF-mediated pathways to control stress-induced cell death.
WWOX inhibits Wnt signalling, probably by sequestering DVL2 in the cytoplasm, and contributes to TGFB1 signalling.
Disruption of WWOX is linked to spinocerebellar ataxia 12, and the protein is required for normal bone development.
WWOX is a putative oxidoreductase that acts as a tumour suppressor and plays a role in apoptosis. It is required for normal bone development, contributes to TGFB1 signalling, and inhibits Wnt signalling, probably by sequestering DVL2 in the cytoplasm.
WWOX is also known as FOR, WOX1 and SDR41C1, and its full name is WW domain containing oxidoreductase. Alternative splicing of the gene results in multiple transcript variants. Check the datasheet of any product for its validated reactivity.
WWOX spans the FRA16D fragile site, and defects are associated with multiple cancers. Disruption is also linked to autosomal recessive spinocerebellar ataxia 12. Mouse has an ortholog, Wwox, and disrupting a similar mouse gene impairs steroidogenesis.
Pathway partners of WWOX, including p53, TGFB1, DVL2 and TNF, with related products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NZC7; product specifications from Assay Genie datasheets.